3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Uterine Cervical Neoplasms
2
Uterine Cervical Dysplasia
1
Solid Tumor
1
Hepatitis B
1
Gallstones
1
Depression
1
Condylomata Acuminata
1
Carcinoma, Hepatocellular
1
Anxiety Disorders
1
Interventions
Trichloroacetic Acid
3
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
3
human papillomavirus vaccine, L1 type 16, 18
2
Vaccines
2
Papillomavirus Vaccines
2
Human Papillomavirus Recombinant Vaccine nonavalent
2
Ethanol
2
nanocurcumin
1
hecolin
1
Zinc
1
Vaccination
1
Tuberculin
1
Surgical Procedures, Operative
1
Podophyllin
1
PRA1 protein, Candida albicans
1
Medical Records
1
Measles-Mumps-Rubella Vaccine
1
Lasers, Gas
1
Imiquimod
1
Hepatitis B Vaccines
1
Electrocoagulation
1
Diathermy
1
Cyclophosphamide
1
Curcumin
1
Cryotherapy
1
Cantharidin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Condylomata Acuminata
×
Hepatitis B Vaccines
×
Clear all
NCT02750202
2026-01-23
TheraVACCS
University of Pretoria
Phase 3
Completed
52 enrolled
34 charts